-
-
-
-
-
-
-
Repligen names Dr. Martin Madaus as board chair as Tony Hunt retires
-
-
-
-
-
-
-
Repligen (RGEN) PT Lowered to $190 at JPMorgan, 'All in, we applaud RGEN’s consistent performance during the bioprocessing recovery'
-
-
-
-
-
-
-
Repligen (RGEN) Launches the CTech SoloVPE PLUS System
-
-
-
-
-
-
-
Repligen (RGEN) Has Approached Maravai Lifesciences (MRVI) with an Acquisition Offer - Reuters
-
-
-
-
-
-
-
Repligen Reports Fourth Quarter and Full Year 2023 Financial Results
-
-
-
-
-
-
-
Repligen Reports Fourth Quarter and Full Year 2022 Financial Results
-
-
-
-
-
-
-
Repligen Reports First Quarter 2022 Financial Results and Updates Full Year 2022 Financial Guidance
-
1,170,313 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

